CG
WST icon

Colony Group’s West Pharmaceutical WST Stock Holding History

Colony Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,080
Closed -$58K – 799
2014
Q4 		$58K Hold
1,080
– – 0.01% 430
2014
Q3 		$48K Sell
1,080
-16,663
-94% -$708K 0.01% 427
2014
Q2 		$748K Buy
17,743
+977
+6% +$41.8K 0.1% 143
2014
Q1 		$739K Buy
16,766
+3,756
+29% +$177K 0.1% 148
2013
Q4 		$638K Buy
13,010
+1,982
+18% +$92.8K 0.09% 147
2013
Q3 		$453K Sell
11,028
-3,428
-24% -$131K 0.09% 115
2013
Q2 		$507K Buy
+14,456
New +$476K 0.1% 117

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Colony Group's WST Position: Q1 2015 in Review

Colony Group sold out of West Pharmaceutical (WST) in Q1 2015, closing a stake of 1,080 shares — an estimated $58K sold.

Colony Group first reported a position in WST in Q2 2013 and held it in 7 quarters. The position peaked at $748K in Q2 2014. 214 funds tracked by Wall St. Rank hold WST as of Q1 2015.

  • Colony Group reported no remaining West Pharmaceutical position as of Q1 2015 after selling out during the quarter.
  • Colony Group sold 1,080 West Pharmaceutical shares in Q1 2015, an estimated $58K.
  • Colony Group first reported a position in West Pharmaceutical in Q2 2013 and held it in 7 quarters.
  • Colony Group's West Pharmaceutical position peaked at $748K in Q2 2014.
  • 214 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2015.

Based on Colony Group's 13F filing for Q1 2015, filed 21 May 2015.